Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland

NCT07516912 | Not Yet Recruiting

• 2 other identifiers: feSTIBASEC-Nr: 2025-02292
• Study Type: observational
• Target: 1,800
• Locations: 0 countries
• Sites: N/A

Brief Summary

The main goal of the observational study is to evaluate participants' satisfaction with free HIV and sexually transmitted infection (STI) testing and counselling offered by the cities of Lucerne and Zurich, Switzerland to young people and people with low incomes. Counselling and testing can be accessed without participating in the study arm of the project.

Conditions

HIV (Human Immunodeficiency Virus); Chlamydia; Gonorrhea; Syphilis; HCV

Keywords

Voluntary counselling and testing; sexually transmitted infections; HIV; implementation of free testing; barriers to care

Outcome Measures

Primary Outcomes (1)

• Participants' satisfaction (study-specific satisfaction scale)

  Participants' satisfaction is measured as the proportion of participants who "agree" or "strongly agree" with satisfaction statements in the post-visit questionnaire. 5-point Likert scale (1 = strongly disagree, 5 = strongly agree); higher scores indicate greater agreement, thus higher satisfaction.

  3 years

Secondary Outcomes (14)

• Service capacity/utilisation

  3 years

• Access timeliness

  3 years

• Workload healthcare providers

  3 years

• Count diagnosed HIV/STI cases

  3 years

• Number of treated STI cases

  3 years

Study Arms (1)

Participants in municipal free HIV and STI counselling and testing pilot programmes

Participants are people accessing the municipal free HIV and STI counselling and testing pilot programmes. People can be eligible by age or low income.

Eligibility Criteria

• Age: 16 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

People living in the cities of Lucerne and Zurich, and fullfilling the eligibility criterias of the city programmes either in age or level of income.

You may qualify if:

• taking part in the pilot programmes
• understand the study information
• years of age or older

You may not qualify if:

• not eligible for the pilot programmes
• not understanding the study information
• less than 16 years old

Sponsors & Collaborators

• University of Zurich: lead
• Checkpoint Zurich: collaborator
• Checkpoint Lucerne: collaborator
• Test-In Zurich: collaborator

Related Links

• Study infromation

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome; Chlamydia Infections; Gonorrhea; Syphilis; Sexually Transmitted Diseases

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases; Chlamydiaceae Infections; Gram-Negative Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Sexually Transmitted Diseases, Bacterial; Neisseriaceae Infections; Treponemal Infections; Spirochaetales Infections; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Andrea C Farnham, PhD

CONTACT

+41 44 634 60 00; testi@ebpi.uzh.ch

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD

Study Record Dates

• First Submitted: March 23, 2026
• First Posted: April 8, 2026
• Study Start: April 7, 2026
• Primary Completion (Estimated): November 30, 2028
• Study Completion (Estimated): February 28, 2029
• Last Updated: April 8, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share